On Friday, Ethiopia confirmed its first outbreak of Marburg virus fever, with nine cases reported in Jinka, South Ethiopia Region. Laboratory confirmation of these cases triggered immediate contact tracing, isolation, and community risk communication to contain hemorrhagic fever.
The World Health Organization reported 9 new cases it had detected in Jinka and stated that it was providing support to response teams with supplies and expertise. The Africa CDC issued a notice that the alert was raised on November 12 and called for heightened vigilance across borders.
Three patients have died among confirmed infections, according to Reuters as relayed by the Health Ministry; further deaths are under investigation. Authorities are widening surveillance and deploying rapid response teams across South Omo.
Marburg virus is a hemorrhagic fever marked by sudden fever, vomiting, and bleeding of the orifices. It is transmitted through contact with secretions or blood from infected individuals, as well as through contact with contaminated materials that have previously been in contact with such individuals. There is currently no approved vaccine or antiviral treatment; however, supportive measures can increase survival, according to the ECDC factsheet.
Earlier episodes underscore the risk and need for prompt containment. A 2005 WHO update from Angola described the largest known event, and a 2017 WHO announcement from Uganda shows how swift mobilization limited the extent of the infection.
Neighbors are on high alert; local media reports South Sudan has issued a public advisory in connection with the Jinka cluster, with border screening and preparations reinforced.
People are advised to avoid contact with the ailing or the dead, and to practice safe burial. If symptoms flare up, individuals should seek medical attention promptly. Testing, isolation, and upfront risk communications are crucial to curbing Marburg Virus transmission.
